基本信息
浏览量:0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
I have completed my studies in Biochemistry and Biotechnology holding a MSc
degree in Applications of Molecular Medicine and a PhD degree in Biochemistry. During my PhD I focused on tumour biology and discovered new modifications of the Hypoxia Inducible Factor (HIF-1) obtaining at the same time strong expertise in state-of-the-art Biochemical and Molecular Biology techniques. Following my PhD, I continued my career as a postdoctoral researcher at IGBMC in France, where I worked on DNA damage and repair in the context of chromatin and nuclear organisation. Using siRNA and drug screening approaches, I described the functional role of several new chromatin related proteins or drugs in DNA damage and repair. During this time, I gained extensive experience in many molecular biology techniques including cell line engineering, genome editing, molecular cloning as well as Proteomics, Genomics, Microscopy and Flow Cytometry. After my postdoc, I joined the Frankfurt CRISPR/Cas Screening Centre (FCSC) - a part of IBC2 and the newly founded start-up company Vivlion GmbH – to support the work of the platform as a Staff Scientist/Postdoc. At FCSC, I generated toolsand reagents to facilitate the development of CRISPR screenings (single or double gRNA lentiviral vectors, gRNA libraries, Cas9 cell lines, NGS sample preparation etc).
Currently, I am a Senior Scientist at Samsara Therapeutics focusing on cell-based assay development for high throughput drug screening, target validation and deciphering drug mode of action.
研究兴趣
论文作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn